No Significant Differences in Antidepressant Remission and Response Rates Between Anxious and Nonanxious Depression: A Multicenter Study in Taiwan
Keine signifikanten Unterschiede in Remissions- und Ansprechraten auf Antidepressiva zwischen ängstlicher und nicht ängstlicher Depression: multizentrische Studie in Taiwan
Depression and Anxiety · 2026-01 · 2026 (1)
DOI: 10.1155/da/3138685 ↗Auf einen Blick
In 302 Patient:innen mit MDD unterschied sich die Wirksamkeit von Escitalopram oder Paroxetin zwischen ängstlicher und nicht ängstlicher Depression nicht signifikant. Die HAM-D-Remissions- und Ansprechraten waren ähnlich.
Fragestellung
Beeinflusst ängstliche Depression die Wirksamkeit von Antidepressiva bei erwachsenen Patient:innen mit MDD in Taiwan?
Methode
Multizentrische, einfach verblindete Studie in 5 Kliniken in Taiwan; Behandlung mit Escitalopram oder Paroxetin; Auswertung nach 8 Wochen.
Ergebnisse
302 Patient:innen: 193 mit ängstlicher und 109 mit nicht ängstlicher Depression. Remission 40,4 % vs. 43,1 %; adjustiertes OR 0,9 (95 %-KI 0,6–1,5). Response 62,2 % vs. 56,9 %; OR 1,2 (95 %-KI 0,7–1,9).
Einschränkungen
Nur 8 Wochen Behandlung; Autoren nennen größere und besser ausbalancierte prospektive Studien als nötig.
Schlussfolgerung der Autor:innen
In dieser ambulanten Kohorte in Taiwan war ängstliche Depression nicht signifikant mit niedrigeren Remissions- oder Ansprechraten unter Escitalopram oder Paroxetin assoziiert.
Kernaussagen
- Remission: 40,4 % vs. 43,1 %
- Response: 62,2 % vs. 56,9 %
- Keine signifikanten Unterschiede bei HAM-D und BDI-II
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Multizentrische Studie in der Zeitschrift Depression and Anxiety, online erschienen am 10.11.2026. Verfasst von Wei-Yang Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry Chang Gung Memorial Hospital Linkou Taoyuan Taiwan cgmh.org.tw. Hauptthemen laut MEDLINE: Paroxetine, Major Depressive Disorder, Escitalopram, Anxiety Disorders. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health Research Institutes, Chang Gung Memorial Hospital.
Themen: Depression
Abstract (Originalsprache)
Background
Anxious depression, defined by coexisting anxiety and depressive symptoms, has been associated with poorer treatment outcomes, though findings remain inconsistent. This study examined whether anxious depression influences antidepressant efficacy in an Asian population.
Methods
This multicenter, single‐blind study across five hospitals was conducted in Taiwan from May 2006 to December 2009. Patients aged 18 and older with major depressive disorder (MDD) were diagnosed and treated with either escitalopram or paroxetine. The Hamilton Rating Scale for Depression (HAM‐D) and the Beck Depression Inventory‐II (BDI‐II) assessed outcomes. Anxious depression was defined as a HAM‐D anxiety factor score ≥ 7. We assessed treatment efficacy by remission and response rates, as well as changes in depression scores.
Results
The study included 302 patients, of whom 193 were classified as having anxious depression and 109 as having nonanxious depression. No significant differences were observed in treatment dosage or duration between the anxious and nonanxious depression groups. HAM‐D‐defined remission rates were 40.4% and 43.1%, respectively (adjusted OR = 0.9, 95% CI = 0.6–1.5, and p = 0.651), and response rates were 62.2% and 56.9% (adjusted OR = 1.2, 95% CI = 0.7–1.9, and p = 0.517). The anxious depression group showed a greater reduction in HAM‐D scores (−13.0 vs. −10.4; adjusted mean difference = −1.9, 95% CI = −3.5 to −0.4, and p = 0.014), whereas the percentage change did not differ significantly between groups (adjusted p = 0.529). BDI‐II outcomes likewise showed no significant between‐group differences. Time to remission (log‐rank p = 0.599) and response (log‐rank p = 0.264) also did not differ significantly.
Conclusions
In this Taiwanese multicenter outpatient cohort, anxious depression was not significantly associated with lower remission or response rates during 8 weeks of treatment with escitalopram or paroxetine. These findings contribute to the limited evidence on antidepressant outcomes among Asian outpatients with anxious depression. However, the absence of statistically significant differences should not be interpreted as evidence of equivalence, and further prospective studies with larger and better‐balanced samples are needed to confirm these findings. Trial Registration: ClinicalTrials.gov identifier: NCT00384020
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry Chang Gung Memorial Hospital Linkou Taoyuan Taiwan cgmh.org.tw.
- Institute of Population Health Sciences National Health Research Institutes Zhunan Miaoli Taiwan nhri.org.tw.
- Graduate Institute of Biostatistics College of Public Health China Medical University Taichung Taiwan cmu.edu.cn.
- Department of Psychiatry Taipei City Psychiatric Center Taipei City Hospital Taipei Taiwan tch.gov.taipei.
- Department of Psychiatry New Taipei City Tucheng Hospital New Taipei Taiwan.
- College of Medicine Chang Gung University Taoyuan Taiwan cgu.edu.tw.
ORCID-Profile: Wei-Yang Lee, Hsiao-Hui Tsou, Si-Yu Chu, Ya-Ting Hsu, Chia-Yih Liu, Chin-Fu Hsiao, Huang-Li Lin
Förderung
- National Health Research Institutes
- Chang Gung Memorial Hospital
Zitieren
APA
Lee, W. Y., Tsou, H. H., Chu, S. Y., Hsu, Y. T., Liu, C. Y., Hsiao, C. F., & Lin, H. L. (2026). No Significant Differences in Antidepressant Remission and Response Rates Between Anxious and Nonanxious Depression: A Multicenter Study in Taiwan. Depression and Anxiety, 2026(1). https://doi.org/10.1155/da/3138685
Vancouver
Lee WY, Tsou HH, Chu SY, Hsu YT, Liu CY, Hsiao CF, et al. No Significant Differences in Antidepressant Remission and Response Rates Between Anxious and Nonanxious Depression: A Multicenter Study in Taiwan. Depression and Anxiety. 2026;2026(1). doi:10.1155/da/3138685
BibTeX
@article{Lee2026,
author = {Lee, Wei-Yang and Tsou, Hsiao-Hui and Chu, Si-Yu and Hsu, Ya-Ting and Liu, Chia-Yih and Hsiao, Chin-Fu and Lin, Huang-Li},
title = {No Significant Differences in Antidepressant Remission and Response Rates Between Anxious and Nonanxious Depression: A Multicenter Study in Taiwan},
journal = {Depression and Anxiety},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/da/3138685}
}
EUVIMED